Clinical Trials Logo

Clinical Trial Summary

The reliability of the Australian Spasticity Assessment Scale (ASAS) has been reported to be not high enough in adult patients with acquired brain damage. The low number of patients and the heterogeneous study population have been reported as important limitations in the reliability study of this measure. Therefore, the reliability of the ASAS needs to be confirmed in stroke patients with spasticity. This study aims to investigate the inter-rater reliability of the ASAS in a study population consisting of a larger and more homogeneous patient population (those with post-stroke spasticity).


Clinical Trial Description

Spasticity is a motor disorder characterized by a velocity-dependent increase in tonic stretch reflex due to upper motor neuron lesion. The prevalence of post-stroke spasticity is between 17-40%. In the assessment of spasticity, although biomechanical and neurophysiological methods provide quantitative data, semi-quantitative methods are mostly used clinically. The most frequently used spasticity measures are the Modified Ashworth Scale and the Modified Tardieu Scale. However, these methods have significant disadvantages. Therefore, the search for more reliable clinical measures continues. One of the newly developed clinical scales is called the Australian Spasticity Assessment Scale (ASAS). Although ASAS has been reported to have a high level of reliability in children with cerebral palsy, the same has not been detected in adult patients with acquired brain damage. The low number of patients and the heterogeneous study population have been reported as two of the important limitations in the reliability study of this measure. In this study, researchers aim to investigate the inter-rater reliability of the ASAS in a study population consisting of a larger and more homogeneous patient population (those with post-stroke spasticity). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04613661
Study type Observational
Source Izmir Katip Celebi University
Contact
Status Completed
Phase
Start date October 20, 2020
Completion date December 17, 2021

See also
  Status Clinical Trial Phase
Terminated NCT04113525 - Transcutaneous Spinal and Peripheral Stimulation and Wrist Robotic Therapy for Patients With Spastic Stroke N/A
Completed NCT03321097 - Condensed and Distributed Robotic Therapy in Spastic Stroke Post Botulinum Toxin Injection N/A
Not yet recruiting NCT03621423 - The Use of Ultrasound for Botulinum Toxin Subscapularis Muscle Injection Guidance in Spastic Hemiplegic Shoulder Pain N/A
Completed NCT03788629 - THE EFFECTS OF SUBTALAR JOINT MOBILIZATION ON PATIENTS WITH CHRONIC STROKE N/A
Completed NCT03807557 - Robotic Modified Constraint -Induced Therapy in Patients With Spastic Hemiplegic Stroke Post Botulinum Toxin A Injection N/A
Completed NCT04939493 - Use of Rhythmic Auditory Cueing During Bilateral Training of the Upper Extremities in Stroke Patients N/A
Recruiting NCT05557305 - Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy N/A
Completed NCT05889026 - The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity N/A
Completed NCT01336517 - Evaluation of the Effect of an Ankle Foot Orthoses for Ambulatory Function N/A
Recruiting NCT05767437 - The Effects of Reaching Task Following Selective Trunk Stability Exercise N/A
Recruiting NCT05683158 - Compensatory Kinematic Movements in Various Directions After Stroke
Completed NCT04826900 - Wearable Robotic System and Robotic Mirror Therapy in Spastic Hemiplegia Post Botulinum Toxin Injection N/A